生物科技
生物科技 行业板块共有183只股票，证券市值逐项合计$1.11T，今日平均上涨4.65%，近1年平均上涨58%。
股票数183
证券市值逐项合计$1.11T
今日平均涨跌▲ 4.65%
近1年平均涨跌▲ 58.1%
市盈率中位数20.5
平均股息率0.74%
今日领涨
本组涨幅最大的股票
今日领跌
本组跌幅最大的股票
涨跌分布
当前有多少成分股上涨或下跌
158 上涨 · 23 下跌 · 2 平盘
全部183只股票（按市值从大到小）
| # | 股票 | 价格 | 当日 | 1年 | 市值 | 市盈率（TTM） | 股息率 | 52周区间 |
|---|---|---|---|---|---|---|---|---|
| 1 | VRTX 福泰制药 | $547.09 | ▲ 0.85% | ▲ 33.6% | $138.71B | 35.2 | – | |
| 2 | MRNA 莫德纳 | $254.19 | ▲ 5.27% | ▲ 935.8% | $101.48B | – | – | |
| 3 | REGN 再生元制药 | $904.35 | ▲ 0.16% | ▲ 38.2% | $93.55B | 20.0 | 0.41% | |
| 4 | ARGX 阿根思 | $927.21 | ▲ 3.63% | ▲ 8.5% | $58.31B | 32.1 | – | |
| 5 | ONC 百济神州 | $406.96 | ▲ 5.09% | ▲ 27.2% | $46.49B | 51.8 | – | |
| 6 | GMAB 健玛博 | $53.63 | ▲ 1.69% | ▲ 87.1% | $33.47B | 45.8 | – | |
| 7 | RPRX 皇家制药版税 | $67.30 | ▼ 0.40% | ▲ 77.9% | $29.97B | 44.0 | 1.37% | |
| 8 | ROIV 罗万特科学 | $38.88 | ▲ 6.17% | ▲ 88.6% | $28.08B | – | – | |
| 9 | INSM 英赛德 | $114.41 | ▲ 5.19% | ▼ 39.7% | $25.10B | – | – | |
| 10 | INCY 因赛特制药 | $119.65 | ▲ 1.39% | ▲ 12.9% | $24.39B | 61.0 | – | |
| 11 | BNTX 拜恩泰科 | $87.51 | ▲ 1.92% | ▼ 15.2% | $21.70B | – | – | |
| 12 | ALNY Alnylam 制药 | $155.94 | ▼ 0.46% | ▼ 64.8% | $20.89B | 8.1 | – | |
| 13 | EXEL 艾塞利斯制药 | $69.57 | ▲ 1.25% | ▲ 70.5% | $16.98B | 20.8 | – | |
| 14 | ASND 阿森迪斯制药 | $256.82 | ▲ 1.33% | ▲ 29.9% | $16.90B | 20.5 | – | |
| 15 | JAZZ 爵士制药 | $234.76 | ▲ 3.27% | ▲ 79.0% | $15.07B | 69.5 | – | |
| 16 | BBIO BridgeBio 药 | $74.29 | ▲ 0.03% | ▲ 20.2% | $14.47B | – | – | |
| 17 | TECH 百奥技术 | $72.78 | ▲ 0.17% | ▲ 27.5% | $11.43B | 62.7 | 0.44% | |
| 18 | KYMR 凯美拉治疗 | $131.73 | ▲ 2.82% | ▲ 124.6% | $11.25B | – | – | |
| 19 | PCVX 瓦克赛特生物 | $63.89 | ▲ 3.18% | ▲ 53.4% | $10.11B | – | – | |
| 20 | MDGL 马德里格尔制药 | $399.63 | ▼ 0.12% | ▼ 18.3% | $9.28B | – | – | |
| 21 | TGTX TG治疗公司 | $59.83 | ▲ 3.18% | ▲ 85.6% | $9.16B | 21.8 | – | |
| 22 | IBRX 免疫生物 | $8.64 | ▲ 7.80% | ▲ 305.4% | $9.15B | – | – | |
| 23 | KRYS 科瑞斯塔生物科技 | $300.88 | ▲ 0.21% | ▲ 52.0% | $8.92B | 40.9 | – | |
| 24 | ARWR Arrowhead 制药 | $58.16 | ▲ 1.22% | ▲ 48.3% | $8.22B | – | – | |
| 25 | TWST 特维斯生物科学 | $120.79 | ▲ 0.15% | ▲ 299.0% | $8.01B | – | – | |
| 26 | RYTM 节律制药 | $112.28 | ▲ 6.91% | ▲ 11.9% | $7.78B | – | – | |
| 27 | ABVX 艾比瓦克斯 | $85.73 | ▲ 1.85% | ▼ 18.6% | $7.50B | – | – | |
| 28 | CYTK 赛拓动力学 | $53.69 | ▼ 3.35% | ▼ 10.8% | $7.48B | – | – | |
| 29 | CAI 凯睿思生命科学 | $25.23 | ▼ 3.07% | ▼ 1.5% | $7.24B | 75.3 | – | |
| 30 | AXSM Axsome 制药 | $132.37 | ▲ 1.98% | ▼ 4.2% | $6.96B | – | – | |
| 31 | CGON CG肿瘤制药 | $75.99 | ▲ 17.27% | ▲ 91.5% | $6.74B | – | – | |
| 32 | IONS 艾昂尼斯制药 | $39.42 | ▲ 1.60% | ▼ 46.4% | $6.55B | – | – | |
| 33 | IMVT 免疫万特 | $30.53 | ▲ 7.54% | ▲ 30.7% | $6.31B | – | – | |
| 34 | KOD 科迪亚克科学 | $99.30 | ▲ 9.10% | ▲ 463.2% | $6.24B | – | – | |
| 35 | BLTE 贝莱特生物 | $154.19 | ▲ 7.68% | ▲ 36.2% | $6.21B | – | – | |
| 36 | LGND 利干德制药 | $306.20 | ▲ 2.41% | ▲ 51.2% | $6.12B | 123.0 | – | |
| 37 | MIRM 米鲁姆制药 | $93.72 | ▲ 0.19% | ▲ 37.6% | $6.12B | – | – | |
| 38 | MANE 维拉德美制药 | $138.78 | ▲ 7.92% | – | $5.80B | – | – | |
| 39 | SRRK 学者岩公司 | $46.94 | ▲ 3.16% | ▲ 62.1% | $5.72B | – | – | |
| 40 | COGT 科金特生物科技 | $31.65 | ▲ 6.98% | ▲ 113.5% | $5.49B | – | – | |
| 41 | PTCT PTC制药 | $65.44 | ▼ 0.35% | ▼ 8.8% | $5.47B | – | – | |
| 42 | ERAS 伊拉斯卡制药 | $14.41 | ▲ 8.59% | ▲ 534.8% | $5.04B | – | – | |
| 43 | EWTX Edgewise 制药 | $45.04 | ▲ 15.87% | ▲ 162.5% | $4.93B | 5.4 | – | |
| 44 | CRSP CRISPR 制药 | $50.07 | ▲ 3.11% | ▼ 9.2% | $4.86B | – | – | |
| 45 | DNTH Dianthus 制药 | $86.03 | ▲ 3.64% | ▲ 137.1% | $4.84B | – | – | |
| 46 | TVTX 特拉维尔治疗 | $49.60 | ▲ 1.49% | ▲ 53.4% | $4.76B | – | – | |
| 47 | DFTX Definium 制药 | $33.27 | ▲ 9.59% | ▲ 184.4% | $4.47B | – | – | |
| 48 | RLAY 瑞雷治疗 | $18.60 | ▲ 9.41% | ▲ 207.4% | $4.11B | – | – | |
| 49 | XENE 氙制药 | $39.17 | ▲ 3.95% | ▲ 2.4% | $3.79B | – | – | |
| 50 | IOVA 艾欧凡斯生物治疗 | $8.04 | ▲ 3.88% | ▲ 249.6% | $3.72B | – | – | |
| 51 | ACAD ACADIA 制药 | $21.23 | ▼ 0.05% | ▼ 5.9% | $3.67B | 10.0 | – | |
| 52 | ELVN Enliven 制药 | $49.43 | ▲ 10.36% | ▲ 180.4% | $3.64B | – | – | |
| 53 | TNGX 探戈治疗 | $21.50 | ▲ 3.02% | ▲ 173.2% | $3.63B | – | – | |
| 54 | VKTX 维京治疗 | $26.84 | ▲ 4.07% | ▼ 27.0% | $3.42B | – | – | |
| 55 | DYN Dyne 制药 | $18.07 | ▲ 4.09% | ▼ 1.6% | $3.39B | – | – | |
| 56 | TARS 塔尔苏斯制药 | $68.60 | ▲ 1.60% | ▲ 0.5% | $3.38B | – | – | |
| 57 | CELC 塞尔库伊蒂 | $66.79 | ▲ 4.29% | ▼ 10.4% | $3.28B | – | – | |
| 58 | TLX 泰利克斯制药 | $9.63 | ▲ 2.23% | ▼ 0.8% | $3.26B | 99.3 | – | |
| 59 | VRDN 维里迪安治疗 | $28.49 | ▼ 0.21% | ▲ 3.8% | $3.24B | – | – | |
| 60 | ARQT 阿库提斯生物制药 | $25.55 | ▼ 5.37% | ▲ 5.4% | $3.23B | 116.1 | – | |
| 61 | DNLI Denali 制药 | $20.07 | ▲ 1.77% | ▲ 33.6% | $3.22B | – | – | |
| 62 | IDYA 艾迪亚生物科技 | $31.24 | ▲ 1.93% | ▲ 3.3% | $3.02B | – | – | |
| 63 | ZLAB 再鼎医药 | $25.48 | ▲ 12.74% | ▲ 16.3% | $2.87B | – | – | |
| 64 | ADMA ADMA生物制品 | $12.73 | ▼ 3.63% | ▼ 12.3% | $2.82B | 16.5 | – | |
| 65 | VCEL 维瑞塞尔 | $54.62 | ▲ 5.48% | ▲ 40.3% | $2.79B | 85.3 | – | |
| 66 | BEAM Beam 制药 | $26.41 | ▲ 2.09% | ▲ 18.9% | $2.73B | – | – | |
| 67 | XNCR 赞科 | $35.75 | ▲ 4.99% | ▲ 157.2% | $2.68B | – | – | |
| 68 | RCUS 阿库斯生物科学 | $18.28 | ▲ 3.34% | ▼ 5.3% | $2.63B | – | – | |
| 69 | PVLA 帕维拉治疗 | $175.92 | ▲ 12.16% | ▲ 126.0% | $2.57B | – | – | |
| 70 | PHVS 法瓦瑞斯制药 | $34.39 | ▲ 5.72% | ▲ 59.3% | $2.41B | – | – | |
| 71 | CLDX Celldex 制药 | $29.87 | ▲ 5.66% | ▲ 30.4% | $2.35B | – | – | |
| 72 | COAG Hemab Therapeutics 控股 | $49.02 | ▲ 7.57% | – | $2.29B | – | – | |
| 73 | SEPN 塞普特纳生物 | $48.85 | ▲ 3.17% | ▲ 163.9% | $2.28B | – | – | |
| 74 | IMNM 免疫诺姆 | $18.71 | ▲ 4.50% | ▲ 22.8% | $2.21B | – | – | |
| 75 | AUPH Aurinia 制药 | $16.46 | ▲ 1.54% | ▲ 12.7% | $2.21B | 7.2 | – | |
| 76 | LKFT 湖滨生物治疗 | $33.45 | ▼ 0.33% | ▲ 6.1% | $2.20B | 3.3 | – | |
| 77 | RXRX 递归制药 | $3.52 | ▲ 0.57% | ▼ 23.8% | $2.19B | – | – | |
| 78 | BHVN 百欧海文制药 | $14.48 | ▲ 4.17% | ▲ 75.3% | $2.19B | – | – | |
| 79 | VERA 维拉治疗 | $29.79 | ▼ 1.18% | ▲ 23.1% | $2.15B | – | – | |
| 80 | FTRE 福泰瑞控股 | $21.96 | ▲ 7.33% | ▲ 95.2% | $2.12B | – | – | |
| 81 | VIR 维尔生物技术 | $12.21 | ▲ 10.80% | ▲ 138.0% | $2.09B | – | – | |
| 82 | ZYME 泽姆沃克斯 | $29.63 | ▲ 3.11% | ▲ 80.0% | $2.09B | – | – | |
| 83 | REPL 瑞普利蒙生物 | $21.62 | ▲ 7.99% | ▲ 160.2% | $2.05B | – | – | |
| 84 | TRVI 特雷维治疗 | $14.33 | ▲ 11.87% | ▲ 30.2% | $2.04B | – | – | |
| 85 | TRAX 首轨生物治疗 | $47.90 | ▲ 5.44% | – | $2.01B | – | – | |
| 86 | HRMY 哈莫尼生物科技 | $33.11 | ▲ 1.97% | ▲ 5.3% | $1.94B | 11.0 | – | |
| 87 | ZBIO 泽纳斯生物制药 | $28.26 | ▲ 8.99% | ▼ 15.9% | $1.92B | – | – | |
| 88 | SRPT 萨瑞普塔治疗 | $17.82 | ▲ 1.42% | ▲ 1.1% | $1.91B | – | – | |
| 89 | MAZE 迷宫制药 | $34.19 | ▲ 5.10% | ▲ 19.5% | $1.90B | – | – | |
| 90 | MESO 美索博拉斯特 | $14.27 | ▲ 1.21% | ▼ 2.3% | $1.86B | – | – | |
| 91 | NVAX 诺瓦瓦克斯 | $10.78 | ▲ 10.22% | ▲ 44.9% | $1.78B | – | – | |
| 92 | AGIO Agios 制药 | $29.41 | ▲ 4.03% | ▼ 27.7% | $1.76B | – | – | |
| 93 | ABSI Absci 公司 | $10.17 | ▲ 8.31% | ▲ 204.9% | $1.75B | – | – | |
| 94 | SLS 塞拉斯生命科学 | $8.42 | ▲ 6.85% | ▲ 429.6% | $1.70B | – | – | |
| 95 | BRVE 勇敢之心生物 | $18.60 | ▲ 6.80% | – | $1.67B | – | – | |
| 96 | NRIX 纽瑞克斯制药 | $15.30 | ▲ 3.10% | ▲ 24.3% | $1.67B | 6.3 | – | |
| 97 | PGEN 普雷西根生物 | $4.47 | ▲ 5.92% | ▲ 14.6% | $1.60B | 40.6 | – | |
| 98 | IMCR 免疫核心 | $30.99 | ▲ 9.12% | ▼ 7.5% | $1.60B | – | – | |
| 99 | NTLA 因特利亚制药 | $11.35 | ▲ 2.25% | ▲ 19.2% | $1.59B | – | – | |
| 100 | RARE 超基因医药 | $15.43 | ▼ 0.90% | ▼ 49.6% | $1.57B | – | – | |
| 101 | TYRA 泰拉生物科学 | $21.15 | ▲ 1.24% | ▲ 47.7% | $1.45B | – | – | |
| 102 | KARD 卡迪根 | $15.52 | ▲ 11.98% | – | $1.45B | – | – | |
| 103 | GPCR 结构治疗 | $20.35 | ▲ 6.66% | ▼ 38.0% | $1.45B | – | – | |
| 104 | OCUL 眼科治疗公司 | $6.60 | ▲ 2.57% | ▼ 39.2% | $1.45B | – | – | |
| 105 | AAPG Ascentage 药 | $15.43 | ▲ 1.98% | ▼ 51.4% | $1.44B | – | – | |
| 106 | KRSA 科萨娜生物科技 | $31.05 | ▲ 2.04% | ▲ 173.5% | $1.41B | – | – | |
| 107 | ANAB 安纳普蒂斯生物 | $46.45 | ▲ 1.91% | ▲ 75.7% | $1.39B | 8.3 | – | |
| 108 | LBRX LB制药 | $42.01 | ▲ 10.29% | ▲ 173.7% | $1.36B | 41.4 | – | |
| 109 | INVA 英诺维瓦 | $19.10 | ▼ 0.73% | ▼ 8.4% | $1.36B | 8.1 | – | |
| 110 | MLYS 米纳瑞斯制药 | $15.33 | ▲ 0.59% | ▼ 59.7% | $1.36B | – | – | |
| 111 | ADRX Adarx 制药 | $13.23 | ▼ 0.45% | – | $1.35B | – | – | |
| 112 | AVLN Avalyn 药 | $29.15 | ▲ 9.30% | – | $1.29B | – | – | |
| 113 | GHRS GH研究制药 | $18.61 | ▲ 0.92% | ▲ 37.9% | $1.28B | – | – | |
| 114 | NKTR 奈克塔制药 | $37.26 | ▲ 3.07% | ▼ 33.4% | $1.27B | – | – | |
| 115 | DRTS 阿尔法陶医疗 | $13.72 | ▲ 3.16% | ▲ 255.4% | $1.27B | – | – | |
| 116 | SGP 斯派格拉斯制药 | $36.95 | ▲ 8.41% | – | $1.24B | – | – | |
| 117 | OMER 奥美罗斯制药 | $16.92 | ▼ 0.88% | ▲ 156.8% | $1.22B | 9.8 | – | |
| 118 | VOR 沃生物制药 | $19.88 | ▲ 6.54% | ▲ 6.3% | $1.22B | 0.1 | – | |
| 119 | URGN 尿路基因制药 | $24.75 | ▼ 3.81% | ▲ 6.5% | $1.21B | – | – | |
| 120 | SPTX 海港治疗公司 | $21.50 | ▲ 5.44% | – | $1.15B | – | – | |
| 121 | MRVI 马拉维生命科学 | $7.52 | ▲ 7.74% | ▲ 162.0% | $1.12B | – | – | |
| 122 | JANX 贾纳克斯治疗 | $17.63 | ▲ 9.78% | ▼ 33.4% | $1.08B | – | – | |
| 123 | SVRA 萨瓦拉制药 | $4.83 | ▲ 10.27% | ▲ 22.3% | $992.37M | – | – | |
| 124 | ANRO 阿尔托神经科学 | $25.16 | ▲ 15.04% | ▲ 117.8% | $987.33M | – | – | |
| 125 | MLTX 月湖免疫治疗 | $11.53 | ▲ 6.76% | ▲ 8.5% | $981.28M | – | – | |
| 126 | JBIO 杰德生物科技 | $15.07 | ▲ 6.88% | ▲ 64.0% | $958.41M | – | – | |
| 127 | IMTX 伊玛提克斯 | $6.36 | ▲ 2.91% | ▼ 29.7% | $951.68M | – | – | |
| 128 | ODTX 奥德赛制药 | $19.23 | ▲ 1.85% | – | $924.35M | – | – | |
| 129 | ORIC 奥瑞克制药 | $8.82 | ▲ 3.89% | ▼ 28.6% | $914.22M | – | – | |
| 130 | GLUE 蒙特罗莎治疗 | $10.57 | ▲ 3.12% | ▼ 14.1% | $903.21M | – | – | |
| 131 | IVA 因文蒂瓦 | $3.80 | ▲ 4.68% | ▼ 5.2% | $897.69M | – | – | |
| 132 | CRVS Corvus 制药 | $10.54 | ▲ 8.32% | ▲ 38.7% | $889.08M | – | – | |
| 133 | TBPH 塞拉万斯生物制药 | $0.00 | ▲ 0.00% | – | $884.18M | 16.4 | – | – |
| 134 | AKTS 阿克提斯肿瘤 | $15.82 | ▲ 6.53% | – | $879.90M | – | – | |
| 135 | PHAR 法明制药 | $12.29 | ▼ 0.08% | ▼ 20.3% | $869.86M | 37.2 | – | |
| 136 | MGTX 美拉基因治疗 | $9.00 | ▲ 5.76% | ▲ 6.3% | $864.39M | 10.3 | – | |
| 137 | SNDX 辛迪制药 | $9.54 | ▲ 1.81% | ▼ 36.6% | $858.87M | – | – | |
| 138 | OBX 黑曜石制药 | $13.87 | ▲ 44.43% | – | $856.48M | 21.3 | – | |
| 139 | ANNX 安耐森 | $4.20 | ▲ 4.87% | ▲ 45.8% | $796.23M | – | – | |
| 140 | LXRX 莱西康制药 | $1.78 | ▲ 10.56% | ▲ 42.4% | $792.52M | – | – | |
| 141 | ALMS 阿鲁米斯 | $6.03 | ▲ 3.08% | ▲ 27.8% | $780.49M | – | – | |
| 142 | DNA 银杏生物工程 | $11.29 | ▲ 13.35% | ▲ 26.1% | $760.27M | – | – | |
| 143 | RIGL 里格尔制药 | $39.65 | ▼ 13.26% | ▲ 12.7% | $746.61M | 2.5 | – | |
| 144 | SLDB 索利德生物科学 | $6.59 | ▲ 6.63% | ▲ 62.3% | $735.51M | – | – | |
| 145 | OABI 奥姆尼艾比生物 | $5.03 | ▲ 4.14% | ▲ 264.5% | $733.68M | – | – | |
| 146 | ARDX 阿德莱克斯 | $2.88 | ▼ 3.68% | ▼ 48.5% | $723.95M | – | – | |
| 147 | NVCT 纽维克蒂斯制药 | $20.91 | ▲ 17.74% | ▲ 240.6% | $719.07M | – | – | |
| 148 | SANA Sana生物科技 | $2.37 | ▲ 1.28% | ▼ 42.1% | $710.13M | – | – | |
| 149 | SGMT 萨吉梅生物科学 | $9.85 | ▲ 8.00% | ▲ 31.0% | $698.45M | – | – | |
| 150 | ATTO Attovia 制药 | $15.27 | ▲ 1.80% | – | $697.09M | – | – | |
| 151 | ZVRA 泽夫拉治疗 | $11.59 | ▲ 10.07% | ▲ 31.6% | $689.66M | 9.5 | – | |
| 152 | AURA 奥拉生物科技 | $6.56 | ▲ 3.47% | ▲ 22.6% | $680.30M | – | – | |
| 153 | FDMT 4D Molecular 制药 | $12.25 | ▲ 8.89% | ▲ 16.7% | $676.74M | – | – | |
| 154 | AVBP 艾锐威特生物制药 | $13.64 | ▲ 11.53% | ▼ 24.4% | $672.56M | – | – | |
| 155 | IMMX 艾米克斯生物制药 | $8.06 | ▲ 11.94% | ▲ 155.9% | $669.62M | – | – | |
| 156 | CADL Candel 制药 | $8.75 | ▲ 8.83% | ▲ 73.6% | $669.54M | – | – | |
| 157 | WVE 波浪生命科学 | $3.37 | ▲ 4.50% | ▼ 57.2% | $663.68M | – | – | |
| 158 | ANL Adlai Nortye 集团 | $10.28 | ▲ 6.20% | ▲ 563.2% | $662.01M | – | – | |
| 159 | DSGN Design 制药 | $10.21 | ▲ 5.58% | ▲ 35.1% | $653.81M | – | – | |
| 160 | KURA 库拉肿瘤 | $7.27 | ▲ 6.91% | ▼ 26.3% | $646.74M | – | – | |
| 161 | OLMA 奥莱玛制药 | $7.33 | ▲ 8.43% | ▼ 12.2% | $641.36M | – | – | |
| 162 | GERN 杰龙制药 | $0.99 | ▲ 4.18% | ▼ 7.5% | $637.67M | – | – | |
| 163 | APMD 艾普尼美德 | $15.10 | ▲ 6.64% | – | $628.62M | 3.9 | – | |
| 164 | ACRS Aclaris 制药 | $3.90 | ▲ 8.03% | ▲ 68.1% | $618.59M | – | – | |
| 165 | CLYM 克莱姆生物 | $10.29 | ▲ 16.01% | ▲ 462.3% | $604.42M | – | – | |
| 166 | FTH 费斯治疗 | $22.05 | ▲ 10.69% | ▲ 142.3% | $569.86M | – | – | |
| 167 | SLBT SL科学 | $0.94 | ▲ 4.16% | ▼ 91.0% | $525.71M | – | – | |
| 168 | VALN 瓦尔内瓦疫苗 | $5.51 | ▼ 2.31% | ▼ 36.8% | $524.15M | – | – | |
| 169 | NGNE 神经基因公司 | $25.31 | ▼ 1.33% | ▼ 5.4% | $506.49M | – | – | |
| 170 | GYRE 吉瑞治疗 | $4.76 | ▲ 18.70% | ▼ 34.0% | $504.72M | – | – | |
| 171 | RGNX 瑞珍斯生物 | $7.62 | ▲ 3.25% | ▼ 32.0% | $503.85M | – | – | |
| 172 | CBIO 克雷森特生物制药 | $13.54 | ▲ 4.64% | ▲ 3.1% | $502.93M | – | – | |
| 173 | MNPR 莫诺帕制药 | $71.42 | ▲ 6.25% | ▼ 11.8% | $479.38M | – | – | |
| 174 | CTMX 赛通姆治疗 | $2.19 | ▲ 2.34% | ▼ 39.5% | $477.43M | – | – | |
| 175 | ETRA 伊莱克特拉治疗 | $7.80 | ▲ 6.12% | – | $476.58M | – | – | |
| 176 | EPRX Eupraxia 制药 | $6.89 | ▲ 4.39% | ▲ 26.4% | $455.25M | – | – | |
| 177 | BLSM BlossomHill 制药 | $13.50 | ▲ 9.31% | – | $429.10M | – | – | |
| 178 | PHAT 法瑟姆制药 | $5.25 | ▲ 3.35% | ▼ 60.4% | $426.78M | – | – | |
| 179 | PBYI 彪马 | $8.25 | ▼ 15.56% | ▲ 37.7% | $425.87M | 17.9 | – | |
| 180 | CRMD 科迈迪克斯 | $5.32 | ▲ 1.72% | ▼ 50.6% | $414.66M | 2.4 | – | |
| 181 | ALT 艾尔免疫 | $2.08 | ▲ 5.58% | ▼ 49.4% | $404.60M | – | – | |
| 182 | AVTX Avalo 制药 | $6.93 | ▲ 4.52% | ▼ 54.0% | $400.71M | – | – | |
| 183 | ATAI 阿泰生命科学 | $0.00 | ▲ 0.00% | – | $0.00 | – | – |
"1年"指过去365天的价格变化。市盈率为过去12个月数据。仅供参考，不构成投资建议。